Morgan Stanley (NYSE:MS - Get Free Report) had its price target increased by JPMorgan Chase & Co. from $173.00 to $179.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a "neutral" rating on the financial services provider's stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 11.39% from the company's current price.
MS has been the topic of a number of other reports. The Goldman Sachs Group restated a "neutral" rating on shares of Morgan Stanley in a research report on Tuesday, January 6th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $207.00 price target on shares of Morgan Stanley in a report on Friday, January 16th. Keefe, Bruyette & Woods upped their price target on shares of Morgan Stanley from $202.00 to $210.00 and gave the stock a "moderate buy" rating in a report on Friday, January 16th. Wall Street Zen upgraded Morgan Stanley from a "hold" rating to a "buy" rating in a research report on Friday, January 23rd. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of Morgan Stanley in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, Morgan Stanley has an average rating of "Moderate Buy" and a consensus price target of $187.14.
Check Out Our Latest Research Report on Morgan Stanley
Morgan Stanley Stock Performance
Shares of NYSE:MS traded up $0.24 during trading on Tuesday, hitting $160.69. 4,309,619 shares of the company were exchanged, compared to its average volume of 7,540,687. Morgan Stanley has a 52-week low of $94.33 and a 52-week high of $192.68. The stock has a 50 day moving average of $177.81 and a 200 day moving average of $168.14. The company has a debt-to-equity ratio of 3.39, a current ratio of 0.81 and a quick ratio of 0.81. The company has a market cap of $255.16 billion, a PE ratio of 15.74, a P/E/G ratio of 1.29 and a beta of 1.20.
Morgan Stanley (NYSE:MS - Get Free Report) last announced its quarterly earnings results on Thursday, January 15th. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.28 by $0.40. The company had revenue of $17.90 billion during the quarter, compared to analysts' expectations of $17.69 billion. Morgan Stanley had a return on equity of 16.78% and a net margin of 14.09%.The firm's quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.22 earnings per share. As a group, equities research analysts predict that Morgan Stanley will post 8.56 EPS for the current year.
Insider Transactions at Morgan Stanley
In related news, insider Eric F. Grossman sold 21,555 shares of the business's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $184.00, for a total value of $3,966,120.00. Following the completion of the sale, the insider owned 171,005 shares in the company, valued at $31,464,920. The trade was a 11.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Michael A. Pizzi sold 20,000 shares of the company's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $184.55, for a total value of $3,691,000.00. Following the completion of the sale, the insider directly owned 127,872 shares of the company's stock, valued at approximately $23,598,777.60. This represents a 13.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 129,191 shares of company stock worth $23,736,506. Company insiders own 0.19% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in MS. Motiv8 Investments LLC bought a new stake in Morgan Stanley in the fourth quarter worth $25,000. Olistico Wealth LLC bought a new stake in shares of Morgan Stanley in the 4th quarter valued at about $27,000. Lodestone Wealth Management LLC purchased a new stake in Morgan Stanley during the 4th quarter valued at about $28,000. Nvest Wealth Strategies Inc. bought a new position in Morgan Stanley during the 4th quarter worth approximately $31,000. Finally, Mowery & Schoenfeld Wealth Management LLC increased its stake in Morgan Stanley by 1,855.6% in the 4th quarter. Mowery & Schoenfeld Wealth Management LLC now owns 176 shares of the financial services provider's stock worth $31,000 after purchasing an additional 167 shares during the period. 84.19% of the stock is owned by hedge funds and other institutional investors.
More Morgan Stanley News
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Morgan Stanley’s strategic collaboration push — coverage highlights the EquityZen buyout, Zerohash crypto tie‑up and other deals intended to broaden product distribution and accelerate Wealth/Prime platform growth, supporting the firm’s long‑term franchise narrative. Read More.
- Positive Sentiment: Analyst activity by Morgan Stanley itself is visible and influential — the firm raised price targets and reiterated high‑profile sector calls (examples today include MS analysts updating coverage on Nu Holdings and reinstating top AI‑chip picks), which reinforces MS’s reputation as a market mover and supports client/institutional flows. Read More. · Read More.
- Positive Sentiment: MS research/upgrades are supporting sector momentum — examples: MS upgraded CrowdStrike (cybersecurity) and maintained active coverage across several high‑beta tech names, which can indirectly support MS trading and advisory revenue expectations by strengthening market sentiment. Read More.
- Neutral Sentiment: Morgan Stanley (Asia) executed a block purchase (Nazara Technologies stake) — an asset/institutional trade that shows the firm’s principal/institutional activity but has limited direct impact on MS share fundamentals. Read More.
- Neutral Sentiment: MS research updates continue across client coverage (Grainger, First Solar, IBM and others) — routine analyst target/coverage changes signal active desks but are mixed in directional impact on MS’s own earnings; they support the bank’s recurring research/advisory franchise. Read More. · Read More.
- Negative Sentiment: Jefferies downgraded Morgan Stanley from "strong‑buy" to "hold" — an outside sell‑side downgrade can pressure sentiment and trigger short‑term selling or reduced momentum. Read More.
- Negative Sentiment: Headcount reduction headlines — reports that MS is cutting roughly 2,500 roles (~3% of workforce) create short‑term uncertainty about execution and signaling, even though management frames cuts as efficiency measures that could help margins over time. Read More.
About Morgan Stanley
(
Get Free Report)
Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.
The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.